Contraction of the guinea pig saphenous artery induced by stimulation of perivascular nerves consists of an adrenergic and a purinergic component. Neuropeptide Y (NPY) potentiated the neural responses significantly at low stimulation frequencies but not at high frequencies when the contraction was maximal. After blocking the adrenoceptors with phentolamine, significant potentiation of the purinergic component by NPY could be demonstrated. The potentiating effect of NPY was abolished in the presence of nifedipine. After desensitizing the purinoceptors with a,38-methylene-ATP, there was no potentiation of the remaining adrenergic component by NPY. NPY also has no effect on contractions induced by exogenous norepinephrine but potentiates those induced by a,4-methylene-ATP. These results suggest that NPY potentiates neurally induced contraction in the guinea pig saphenous artery by a specific action on the purinergic response. (Circulation Research 1991;68:1401-1407 It is now well recognized that neurotransmitters other than norepinephrine may be released from perivascular sympathetic nerves. effect of NPY is modulation of the neural responses by potentiation of vasoconstriction and inhibition of norepinephrine release.6 The effect of NPY on the respective purinergic and adrenergic components of the neural responses is not known. In the present study, we investigated the effect of NPY on neural responses in the guinea pig saphenous artery, a preparatior that we have previously shown to be mediated ')y both purinergic and adrenergic components.37 It was observed that NPY specifically potentiates the purinergic responses in the guinea pig saphenous artery.
It is now well recognized that neurotransmitters other than norepinephrine may be released from perivascular sympathetic nerves. In many vascular preparations, two distinct types of junction potentials, the excitatory junction potential and the slow depolarization,12 have been demonstrated from electrophysiological studies. Only the slow depolarization can be blocked by classical a-adrenoceptor antagonists. In contrast, the excitatory junction potential can be selectively antagonized by arylazido aminopropionyl ATP (ANAPP3)3 or desensitization by a,,/-methylene-ATP (mATP).2 These findings led to the suggestion that ATP is coreleased with norepinephrine from perivascular nerves. 2, 4 Two distinct contraction components with pharmacological properties similar to the excitatory junction potential and the slow depolarization have also been documented in many arterial preparations. 4, 5 Another putative neurotransmitter that is present in perivascular sympathetic nerves is neuropeptide Y (NPY). In some vascular preparations, NPY has a direct vasopressor effect; in others, NPY is not a very effective vasoconstrictive agent.6 A more consistent effect of NPY is modulation of the neural responses by potentiation of vasoconstriction and inhibition of norepinephrine release. 6 The effect of NPY on the respective purinergic and adrenergic components of the neural responses is not known. In the present study, we investigated the effect of NPY on neural responses in the guinea pig saphenous artery, a preparatior that we have previously shown to be mediated ')y both purinergic and adrenergic components.37 It was observed that NPY specifically potentiates the purinergic responses in the guinea pig saphenous artery.
Materials and Methods
The experimental procedure was similar to that previously reported from our laboratory.7 Ring segments of saphenous artery about 5 mm in length were isolated from male guinea pigs (300-400 g, Charles Rivers Laboratories, Inc Figure 4 ). The potentiating effect of NPY was frequency dependent, being most significant at the lowest stimulation frequency ( Figure 5 ). At 0.5 Hz, the response in the presence of NPY already reached 81% of the maximum, compared with only 17% in control. Increasing the stimulation frequency augments the potentiating effect only slightly.
In some arterial preparations, the purinergic component of the neural response is sensitive to the action of nifedipine.8 In the present study, nifedipine (6 ,uM) also significantly inhibited the purinergic contractions by roughly 50% in the guinea pig saphenous artery at all stimulation frequencies ( Figure 6 ). In the presence of nifedipine, NPY (47 mM) failed to potentiate the purinergic contractions, and the responses were not significantly different from those with nifedipine alone (Figure 6 ). (Figures 3 and 4) . When the purinoceptors were blocked by mATP, the remaining adrenergic contraction was smooth, and single contraction peaks were no longer discernible (Figure 8 ). 
Effect of NPY on Contractions Induced by
Norepinephrine and mATP The effects of NPY on postsynaptic purinoceptors and a-adrenoceptors were tested by contractions induced by mATP and norepinephrine, respectively. Cumulative addition of mATP resulted in contraction of the vessel. The maximal contraction induced by mATP was 93.5+±2% of that of norepinephrine. No desensitization effect was observed if the doses were added within the 8 minutes required to complete the dose-response study. However, a washout period of about 1 hour was required for the contraction to mATP to recover fully from desensitization for subsequent dose-response studies. In the presence of NPY (47 nM), the mATP responses were significantly potentiated ( Figure 9A ). The threshold concentration to elicit a response was lowered to 0.1 gM. However, the maximal contraction was not altered by NPY.
The effect of NPY on postsynaptic a-adrenoceptors was studied by contraction responses to cumulative doses of norepinephrine. NPY (47 nM) had no significant effect on the responses to norepinephrine at all doses ( Figure 9B ). Thus, in this preparation, the potentiation effect of NPY is specific to the postsynaptic purinoceptors, and the a-adrenoceptors were not directly affected. Discussion In certain arteries (e.g., guinea pig saphenous artery7 and rabbit ear artery9), the neurally mediated responses consist of two pharmacologically distinct components. One is purinergic and can be inhibited by ANAPP3 or desensitized with mATP. The other is ca-adrenergic and can be blocked by prazosin or phentolamine. 7, 9 In the present study, we show that NPY selectively potentiates the purinergic component of the neural responses in the guinea pig saphenous A presynaptic mechanism with NPY selectively enhancing the release of ATP from the nerve terminals is possible but very unlikely. Electrophysiological studies on mesenteric arterioles showed that NPY (50 nM) caused a 28% reduction in the amplitude of the excitatory junction potentials.10 Other reports in the literature indicate that NPY either has no effect'1 or inhibits norepinephrine release12 from perivascular nerves. There are no known cases of NPY enhancing transmitter release. It is more probable that ATP is released simultaneously with norepinephrine, because both components of the nerve responses were abolished after reserpinization (author's unpublished observations). The small but significant decrease in the contraction at a stimulation frequency of 10 Hz in the presence of mATP observed in the present study may be the result of presynaptic inhibition of norepinephrine release.
The study with exogenous agonists suggests that the site of action of the potentiation process is postsynaptic, because NPY also potentiates the contraction to exogenous mATP but not to norepinephrine. In a recent study of the rabbit ear artery, Saville et a19 reported selective potentiation by NPY (0.3 ,uM) of the purinergic component of the neurally induced contraction by more than 50% with stimulation frequencies of calcium entry through voltage-dependent calcium channels. Direct electrophysiological experiments are necessary to determine if NPY increases the amplitude of the action potentials elicited by the excitatory junction potentials and the currents through the calcium channels.
